Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Retained Earnings (2016 - 2025)

AC Immune (ACIU) has disclosed Retained Earnings for 10 consecutive years, with -$549.3 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 30.67% to -$549.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$549.3 million through Dec 2025, down 30.67% year-over-year, with the annual reading at -$549.3 million for FY2025, 30.67% down from the prior year.
  • Retained Earnings for Q4 2025 was -$549.3 million at AC Immune, down from -$420.4 million in the prior quarter.
  • The five-year high for Retained Earnings was -$217.9 million in Q4 2021, with the low at -$549.3 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$363.6 million, with a median of -$356.5 million recorded in 2023.
  • The sharpest move saw Retained Earnings tumbled 48.29% in 2021, then decreased 17.92% in 2024.
  • Over 5 years, Retained Earnings stood at -$217.9 million in 2021, then dropped by 25.76% to -$274.1 million in 2022, then tumbled by 30.07% to -$356.5 million in 2023, then fell by 17.92% to -$420.4 million in 2024, then plummeted by 30.67% to -$549.3 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$549.3 million, -$420.4 million, and -$356.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.